CSE’s Anil Mall chats with Jeff Stevens, CEO of Psyched Wellness Ltd. (CSE:PSYC) to discuss the company’s objective to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. Jeff also shares how they are developing a line of Amanita Muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief and relaxation, assist with sleeping and to support mood.
Here’s an overview of what Anil and Jeff cover in this edition of the #HashtagFinance podcast:
0:00 – Introducing Jeff Stevens CEO of Psyched Wellness
2:30 – The company’s mission to harness the healing power of mushrooms
6:00 – The science and history of Amanita Muscaria
9:00 – Professor David Nutt – a thought leader in Amanita Muscaria
11:20 – Michael Nederhoff, Terry Booth and the PSYC Board
16:00 – Psyched’s developing product line
17:20 – The R&D required to launch a micro dose product
20:30 – Keeping up with Psyched
22:50 – Closing comments – the value proposition
Learn more about Psyched Wellness at: https://thecse.com/en/listings/life-sciences/psyched-wellness-ltd
